Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Laparoscopic Gastric Bypass Versus Sleeve Gastrectomy to Treat Morbid Obesity (SLEE-PASS)
This study is enrolling participants by invitation only.
Sponsored by: Turku University Hospital
Information provided by: Turku University Hospital
ClinicalTrials.gov Identifier: NCT00793143
  Purpose

Bariatric surgery in the treatment of morbid obesity is associated with long-term weight-loss and decreased overall mortality. Long-term results have been reported for laparoscopic gastric bypass procedures but the long-term results of laparoscopic sleeve gastrectomy are yet unavailable. As sleeve gastrectomy is a rapid and less traumatic procedure with good short-term results of weight loss and resolution of comorbidities, the investigators initiated a prospective randomized two-center study comparing laparoscopic sleeve gastrectomy (LSG)with laparoscopic gastric bypass (LGB) in the treatment of morbid obesity. Study hypothesis: As sleeve gastrectomy is less traumatic, easier and faster to perform compared with gastric bypass,LSG could become the procedure of choice to treat morbid obesity if the long-term results of weight loss and resolution of comorbidities are comparable with laparoscopic gastric bypass.


Condition
Morbid Obesity

MedlinePlus related topics: Obesity Weight Control
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: A Randomized Prospective Two-Center Study: Laparoscopic Gastric Bypass vs. Laparoscopic Sleeve Gastrectomy in the Treatment of Morbid Obesity

Further study details as provided by Turku University Hospital:

Primary Outcome Measures:
  • Resolution of comorbidities [ Time Frame: 3,6,12,18 months, 2,3,5,7,10,15 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Excessive weight loss [ Time Frame: 3,6,12,18 months, 2,3,5,7,10,15 years ] [ Designated as safety issue: No ]
  • Mortality [ Time Frame: 0 - 15 years ] [ Designated as safety issue: Yes ]
  • Morbidity [ Time Frame: 0 - 15 years ] [ Designated as safety issue: Yes ]
  • QOL (15D and BAROS) [ Time Frame: 3,6,12,18 months, 2,3,5,7,10,15 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Tissue samples


Enrollment: 160
Study Start Date: April 2008
Estimated Study Completion Date: May 2025
Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Sleeve
Bypass

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients rederred to two tertiary referral hospitals (Turku University Central Hospital and Vaasa Central Hospital)for treatmnet of morbid obesity

Criteria

Inclusion Criteria:

  • BMI > 40 or BMI > 35 with a comorbidity associated with obesity
  • Age 18 - 60 years
  • Failed prior effective and controlled conservative treatments of morbid obesity

Exclusion Criteria:

  • BMI > 60
  • Difficult psychiatric conditions or lack of co-operation
  • Difficult eating disorder (binge eating, bulimia etc.)
  • Alcohol abuse
  • Gastric ulcer
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00793143

Locations
Finland
Department of Surgery, Turku University Central Hospital
Turku, Finland, 20520
Vaasa Central Hospital
Vaasa, Finland
Sponsors and Collaborators
Turku University Hospital
Investigators
Principal Investigator: Paulina Salminen, MD, PhD Turku Univeristy Central Hospital
Principal Investigator: Jari Ovaska, Md, PhD University of Turku
Principal Investigator: Mikael Victorzon, MD, PhD Vaasa Central Hospital
  More Information

Responsible Party: Turku University Central Hospital, Department of surgery ( Paulina Salminen )
Study ID Numbers: SLEE-PASS
Study First Received: November 17, 2008
Last Updated: November 18, 2008
ClinicalTrials.gov Identifier: NCT00793143  
Health Authority: Finland: Ethics Committee

Keywords provided by Turku University Hospital:
morbid obesity
laparoscopic sleeve gastrectomy
LSG
laparoscopic gastric bypass
LGB
comorbidities
diabetes
excessive weight loss
weight loss

Study placed in the following topic categories:
Body Weight
Signs and Symptoms
Obesity
Weight Loss
Diabetes Mellitus
Nutrition Disorders
Overweight
Overnutrition
Obesity, Morbid

ClinicalTrials.gov processed this record on January 15, 2009